Efeitos de autoanticorpos antilipoproteína lipase, antilipoproteína de baixa densidade e antilipoproteína de baixa densidade oxidada sobre o metabolismo lipídico e ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-10

AUTHORS

James Fesmire, Marianne Wolfson-Reichlin, Morris Reichlin

ABSTRACT

INTRODUCTION: Premature development of atherosclerosis in systemic lupus erythematosus has been widely reported. Anti-lipoprotein lipase antibody may be one cause contributing to this disorder. OBJECTIVE: To assess the extent of coronary risk due to autoimmune antibodies in terms of carotid plaque in lupus patients. PATIENTS AND METHODS: We compared 114 documented lupus patients with 111 normal controls matched for sex and age. Anti-lipoprotein lipase (A-LPL), anti-oxidized low density lipoprotein (A-OXLDL), and anti-low density lipoprotein (A-LDL) were measured by enzme-linked immunoabsorbent assay. Low density lipoprotein-triglyceride (LDL-Trig) and high density lipoprotein-triglyceride (HDL-Trig) were also measured. Plaque was measured by bilateral carotid ultrasound. RESULTS: 45.6% of patients tested positive for A-LPL, and 34.4% for A-OXLDL. 44% of normal controls tested positive for A-LPL, and 20% for A-OXLDL. Risk increased sharply in subgroups with increased antibody levels. Patients with A-LPL and A-OXLDL > 0.40 (n = 12) showed coronary risk correlations of: A-LPL x LDL-Trig = 0.7008, P = 0.0111; bilateral ultrasound vs total cholesterol = 0.62205, P = 0.0308; LDL-Trig vs myocardial infarction (MI) = 0.76562, P = 0.0037; total triglycerides vs MI = 0.78191, P = 0.0027); LDL-Trig/LDL-cholesterol vs MI = 0.80493, P = 0.0016; A-OXLDL vs USBL = 0.71930, P = 0.0084. Correlations of SLEDAI with risk variables were highly significant only in subgroups of elevated antibody levels (SLEDAI x A-OXLDL = 0.70366, P = 0.0107). CONCLUSION: A-LPL initiates the development of LDL mutations, followed by antibody production, plaque formation and coronary risk in some SLE patients. More... »

PAGES

539-551

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1590/s0482-50042010000500007

DOI

http://dx.doi.org/10.1590/s0482-50042010000500007

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021847790

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21125190


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1101", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biochemistry and Metabolomics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atherosclerosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoantibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipid Metabolism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoprotein Lipase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipoproteins, LDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lupus Erythematosus, Systemic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Oklahoma Medical Research Foundation", 
          "id": "https://www.grid.ac/institutes/grid.274264.1", 
          "name": [
            "Oklahoma Medical Research Foundation, Oklahoma, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fesmire", 
        "givenName": "James", 
        "id": "sg:person.0707005107.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707005107.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oklahoma Medical Research Foundation", 
          "id": "https://www.grid.ac/institutes/grid.274264.1", 
          "name": [
            "Oklahoma Medical Research Foundation, Oklahoma, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wolfson-Reichlin", 
        "givenName": "Marianne", 
        "id": "sg:person.0773247372.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773247372.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Oklahoma Health Sciences Center", 
          "id": "https://www.grid.ac/institutes/grid.266902.9", 
          "name": [
            "Oklahoma Medical Research Foundation, Oklahoma, USA", 
            "University of Oklahoma Health Sciences Center, Oklahoma City, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reichlin", 
        "givenName": "Morris", 
        "id": "sg:person.01012367420.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012367420.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/art.20630", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013538256"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.10624", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017306247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.atv.12.11.1336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018832210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11886-009-0004-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020247442", 
          "https://doi.org/10.1007/s11886-009-0004-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.298.3.299", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022671129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci103182", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022688685"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/096120339700600610", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023640885"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/096120339700600610", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023640885"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/096120339700600610", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023640885"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000146898.06923.80", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029885941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.atv.10.3.325", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032666416"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2459/jcm.0b013e32832e62fd", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042517790"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2459/jcm.0b013e32832e62fd", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042517790"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.1780251101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051582030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077031278", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078621898", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080284174", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081966418", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007611-199310000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082703903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007611-199310000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082703903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00007611-199310000-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082703903"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-10", 
    "datePublishedReg": "2010-10-01", 
    "description": "INTRODUCTION: Premature development of atherosclerosis in systemic lupus erythematosus has been widely reported. Anti-lipoprotein lipase antibody may be one cause contributing to this disorder.\nOBJECTIVE: To assess the extent of coronary risk due to autoimmune antibodies in terms of carotid plaque in lupus patients.\nPATIENTS AND METHODS: We compared 114 documented lupus patients with 111 normal controls matched for sex and age. Anti-lipoprotein lipase (A-LPL), anti-oxidized low density lipoprotein (A-OXLDL), and anti-low density lipoprotein (A-LDL) were measured by enzme-linked immunoabsorbent assay. Low density lipoprotein-triglyceride (LDL-Trig) and high density lipoprotein-triglyceride (HDL-Trig) were also measured. Plaque was measured by bilateral carotid ultrasound.\nRESULTS: 45.6% of patients tested positive for A-LPL, and 34.4% for A-OXLDL. 44% of normal controls tested positive for A-LPL, and 20% for A-OXLDL. Risk increased sharply in subgroups with increased antibody levels. Patients with A-LPL and A-OXLDL > 0.40 (n = 12) showed coronary risk correlations of: A-LPL x LDL-Trig = 0.7008, P = 0.0111; bilateral ultrasound vs total cholesterol = 0.62205, P = 0.0308; LDL-Trig vs myocardial infarction (MI) = 0.76562, P = 0.0037; total triglycerides vs MI = 0.78191, P = 0.0027); LDL-Trig/LDL-cholesterol vs MI = 0.80493, P = 0.0016; A-OXLDL vs USBL = 0.71930, P = 0.0084. Correlations of SLEDAI with risk variables were highly significant only in subgroups of elevated antibody levels (SLEDAI x A-OXLDL = 0.70366, P = 0.0107).\nCONCLUSION: A-LPL initiates the development of LDL mutations, followed by antibody production, plaque formation and coronary risk in some SLE patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1590/s0482-50042010000500007", 
    "inLanguage": [
      "pt"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2440092", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438766", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438391", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1018588", 
        "issn": [
          "0482-5004", 
          "2523-3106"
        ], 
        "name": "Advances in Rheumatology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "50"
      }
    ], 
    "name": "Efeitos de autoanticorpos antilipoprote\u00edna lipase, antilipoprote\u00edna de baixa densidade e antilipoprote\u00edna de baixa densidade oxidada sobre o metabolismo lip\u00eddico e aterosclerose no l\u00fapus eritematoso sist\u00eamico", 
    "pagination": "539-551", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6816e8c6cb2d70df0c404cf0abab4892e9ae95de63b14816ee90463bb3a1d8ac"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21125190"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0404256"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1590/s0482-50042010000500007"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021847790"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1590/s0482-50042010000500007", 
      "https://app.dimensions.ai/details/publication/pub.1021847790"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:47", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000037.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042010000500007&lng=pt&nrm=iso&tlng=pt"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1590/s0482-50042010000500007'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1590/s0482-50042010000500007'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1590/s0482-50042010000500007'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1590/s0482-50042010000500007'


 

This table displays all metadata directly associated to this object as RDF triples.

198 TRIPLES      21 PREDICATES      60 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1590/s0482-50042010000500007 schema:about N021b04350a6b441fbc93f77da2e42695
2 N02eeedcebc444893a19cff585460e428
3 N0d84901aa90549b28a8db7edd5f0ae5d
4 N24acaf9d190a40039b3ed56011c6b7eb
5 N3171343c21d8484bb32e85d98c587461
6 N4ab2f364429e4fc690ccde79536068c0
7 N616cd81e36ab411ca90d0d9cd348b5d3
8 N7ea2a1eaa51a436181137ca35ebefecd
9 N93cd4a036d0b46989df85939bd236574
10 Nc09cff8c432b41e2adda1b72d0c82a30
11 Nc18bcbad12e54d3593e6b830edfe1e07
12 Ne762513ff7d641248ffe232af35f6745
13 Ne815dff1009f4c10a346c78573450662
14 Ned5e2fc5159041918ddce9557433beb2
15 Nef7c262c52ea48498bd939524c224d95
16 anzsrc-for:11
17 anzsrc-for:1101
18 schema:author N2e0ff8f094c44876ad0ba6b180fc67bd
19 schema:citation sg:pub.10.1007/s11886-009-0004-1
20 https://app.dimensions.ai/details/publication/pub.1077031278
21 https://app.dimensions.ai/details/publication/pub.1078621898
22 https://app.dimensions.ai/details/publication/pub.1080284174
23 https://app.dimensions.ai/details/publication/pub.1081966418
24 https://doi.org/10.1001/jama.298.3.299
25 https://doi.org/10.1002/art.10624
26 https://doi.org/10.1002/art.1780251101
27 https://doi.org/10.1002/art.20630
28 https://doi.org/10.1097/00007611-199310000-00001
29 https://doi.org/10.1161/01.atv.10.3.325
30 https://doi.org/10.1161/01.atv.12.11.1336
31 https://doi.org/10.1161/01.cir.0000146898.06923.80
32 https://doi.org/10.1172/jci103182
33 https://doi.org/10.1177/096120339700600610
34 https://doi.org/10.2459/jcm.0b013e32832e62fd
35 schema:datePublished 2010-10
36 schema:datePublishedReg 2010-10-01
37 schema:description INTRODUCTION: Premature development of atherosclerosis in systemic lupus erythematosus has been widely reported. Anti-lipoprotein lipase antibody may be one cause contributing to this disorder. OBJECTIVE: To assess the extent of coronary risk due to autoimmune antibodies in terms of carotid plaque in lupus patients. PATIENTS AND METHODS: We compared 114 documented lupus patients with 111 normal controls matched for sex and age. Anti-lipoprotein lipase (A-LPL), anti-oxidized low density lipoprotein (A-OXLDL), and anti-low density lipoprotein (A-LDL) were measured by enzme-linked immunoabsorbent assay. Low density lipoprotein-triglyceride (LDL-Trig) and high density lipoprotein-triglyceride (HDL-Trig) were also measured. Plaque was measured by bilateral carotid ultrasound. RESULTS: 45.6% of patients tested positive for A-LPL, and 34.4% for A-OXLDL. 44% of normal controls tested positive for A-LPL, and 20% for A-OXLDL. Risk increased sharply in subgroups with increased antibody levels. Patients with A-LPL and A-OXLDL > 0.40 (n = 12) showed coronary risk correlations of: A-LPL x LDL-Trig = 0.7008, P = 0.0111; bilateral ultrasound vs total cholesterol = 0.62205, P = 0.0308; LDL-Trig vs myocardial infarction (MI) = 0.76562, P = 0.0037; total triglycerides vs MI = 0.78191, P = 0.0027); LDL-Trig/LDL-cholesterol vs MI = 0.80493, P = 0.0016; A-OXLDL vs USBL = 0.71930, P = 0.0084. Correlations of SLEDAI with risk variables were highly significant only in subgroups of elevated antibody levels (SLEDAI x A-OXLDL = 0.70366, P = 0.0107). CONCLUSION: A-LPL initiates the development of LDL mutations, followed by antibody production, plaque formation and coronary risk in some SLE patients.
38 schema:genre research_article
39 schema:inLanguage pt
40 schema:isAccessibleForFree true
41 schema:isPartOf N00bd74d427f84989af10a1cac595cfcc
42 Ne50cbe7c686d4d418e69a0e7a89e32f2
43 sg:journal.1018588
44 schema:name Efeitos de autoanticorpos antilipoproteína lipase, antilipoproteína de baixa densidade e antilipoproteína de baixa densidade oxidada sobre o metabolismo lipídico e aterosclerose no lúpus eritematoso sistêmico
45 schema:pagination 539-551
46 schema:productId N44f8de9fc641415fa9a0381fe2440f07
47 N582f19a76d7f4ddb98ce711d7bca77a4
48 N682f0c4844424e51ab907772f7964ca5
49 N8dc22a3c0e0144b9877a442a318bd7f9
50 N98269d825bc54d4da4e0691c8f31927c
51 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021847790
52 https://doi.org/10.1590/s0482-50042010000500007
53 schema:sdDatePublished 2019-04-10T17:47
54 schema:sdLicense https://scigraph.springernature.com/explorer/license/
55 schema:sdPublisher N841ed2f9e3014f0e95b662fba2b92732
56 schema:url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042010000500007&lng=pt&nrm=iso&tlng=pt
57 sgo:license sg:explorer/license/
58 sgo:sdDataset articles
59 rdf:type schema:ScholarlyArticle
60 N00bd74d427f84989af10a1cac595cfcc schema:issueNumber 5
61 rdf:type schema:PublicationIssue
62 N021b04350a6b441fbc93f77da2e42695 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Lipoproteins, LDL
64 rdf:type schema:DefinedTerm
65 N02eeedcebc444893a19cff585460e428 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Adult
67 rdf:type schema:DefinedTerm
68 N0d84901aa90549b28a8db7edd5f0ae5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Middle Aged
70 rdf:type schema:DefinedTerm
71 N24acaf9d190a40039b3ed56011c6b7eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Lipid Metabolism
73 rdf:type schema:DefinedTerm
74 N2e0ff8f094c44876ad0ba6b180fc67bd rdf:first sg:person.0707005107.03
75 rdf:rest N31cbe1d9bd3340c9a07e95e2e604ede0
76 N3171343c21d8484bb32e85d98c587461 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Aged, 80 and over
78 rdf:type schema:DefinedTerm
79 N31cbe1d9bd3340c9a07e95e2e604ede0 rdf:first sg:person.0773247372.78
80 rdf:rest N6b091e474a924d5a826d90579193c055
81 N44f8de9fc641415fa9a0381fe2440f07 schema:name readcube_id
82 schema:value 6816e8c6cb2d70df0c404cf0abab4892e9ae95de63b14816ee90463bb3a1d8ac
83 rdf:type schema:PropertyValue
84 N4ab2f364429e4fc690ccde79536068c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Aged
86 rdf:type schema:DefinedTerm
87 N582f19a76d7f4ddb98ce711d7bca77a4 schema:name nlm_unique_id
88 schema:value 0404256
89 rdf:type schema:PropertyValue
90 N616cd81e36ab411ca90d0d9cd348b5d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Lupus Erythematosus, Systemic
92 rdf:type schema:DefinedTerm
93 N682f0c4844424e51ab907772f7964ca5 schema:name dimensions_id
94 schema:value pub.1021847790
95 rdf:type schema:PropertyValue
96 N6b091e474a924d5a826d90579193c055 rdf:first sg:person.01012367420.16
97 rdf:rest rdf:nil
98 N7ea2a1eaa51a436181137ca35ebefecd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Lipoprotein Lipase
100 rdf:type schema:DefinedTerm
101 N841ed2f9e3014f0e95b662fba2b92732 schema:name Springer Nature - SN SciGraph project
102 rdf:type schema:Organization
103 N8dc22a3c0e0144b9877a442a318bd7f9 schema:name doi
104 schema:value 10.1590/s0482-50042010000500007
105 rdf:type schema:PropertyValue
106 N93cd4a036d0b46989df85939bd236574 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Young Adult
108 rdf:type schema:DefinedTerm
109 N98269d825bc54d4da4e0691c8f31927c schema:name pubmed_id
110 schema:value 21125190
111 rdf:type schema:PropertyValue
112 Nc09cff8c432b41e2adda1b72d0c82a30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Atherosclerosis
114 rdf:type schema:DefinedTerm
115 Nc18bcbad12e54d3593e6b830edfe1e07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Adolescent
117 rdf:type schema:DefinedTerm
118 Ne50cbe7c686d4d418e69a0e7a89e32f2 schema:volumeNumber 50
119 rdf:type schema:PublicationVolume
120 Ne762513ff7d641248ffe232af35f6745 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Humans
122 rdf:type schema:DefinedTerm
123 Ne815dff1009f4c10a346c78573450662 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Male
125 rdf:type schema:DefinedTerm
126 Ned5e2fc5159041918ddce9557433beb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Autoantibodies
128 rdf:type schema:DefinedTerm
129 Nef7c262c52ea48498bd939524c224d95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Female
131 rdf:type schema:DefinedTerm
132 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
133 schema:name Medical and Health Sciences
134 rdf:type schema:DefinedTerm
135 anzsrc-for:1101 schema:inDefinedTermSet anzsrc-for:
136 schema:name Medical Biochemistry and Metabolomics
137 rdf:type schema:DefinedTerm
138 sg:grant.2438391 http://pending.schema.org/fundedItem sg:pub.10.1590/s0482-50042010000500007
139 rdf:type schema:MonetaryGrant
140 sg:grant.2438766 http://pending.schema.org/fundedItem sg:pub.10.1590/s0482-50042010000500007
141 rdf:type schema:MonetaryGrant
142 sg:grant.2440092 http://pending.schema.org/fundedItem sg:pub.10.1590/s0482-50042010000500007
143 rdf:type schema:MonetaryGrant
144 sg:journal.1018588 schema:issn 0482-5004
145 2523-3106
146 schema:name Advances in Rheumatology
147 rdf:type schema:Periodical
148 sg:person.01012367420.16 schema:affiliation https://www.grid.ac/institutes/grid.266902.9
149 schema:familyName Reichlin
150 schema:givenName Morris
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012367420.16
152 rdf:type schema:Person
153 sg:person.0707005107.03 schema:affiliation https://www.grid.ac/institutes/grid.274264.1
154 schema:familyName Fesmire
155 schema:givenName James
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707005107.03
157 rdf:type schema:Person
158 sg:person.0773247372.78 schema:affiliation https://www.grid.ac/institutes/grid.274264.1
159 schema:familyName Wolfson-Reichlin
160 schema:givenName Marianne
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773247372.78
162 rdf:type schema:Person
163 sg:pub.10.1007/s11886-009-0004-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020247442
164 https://doi.org/10.1007/s11886-009-0004-1
165 rdf:type schema:CreativeWork
166 https://app.dimensions.ai/details/publication/pub.1077031278 schema:CreativeWork
167 https://app.dimensions.ai/details/publication/pub.1078621898 schema:CreativeWork
168 https://app.dimensions.ai/details/publication/pub.1080284174 schema:CreativeWork
169 https://app.dimensions.ai/details/publication/pub.1081966418 schema:CreativeWork
170 https://doi.org/10.1001/jama.298.3.299 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022671129
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1002/art.10624 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017306247
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1002/art.1780251101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051582030
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1002/art.20630 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013538256
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1097/00007611-199310000-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082703903
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1161/01.atv.10.3.325 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032666416
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1161/01.atv.12.11.1336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018832210
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1161/01.cir.0000146898.06923.80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029885941
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1172/jci103182 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022688685
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1177/096120339700600610 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023640885
189 rdf:type schema:CreativeWork
190 https://doi.org/10.2459/jcm.0b013e32832e62fd schema:sameAs https://app.dimensions.ai/details/publication/pub.1042517790
191 rdf:type schema:CreativeWork
192 https://www.grid.ac/institutes/grid.266902.9 schema:alternateName University of Oklahoma Health Sciences Center
193 schema:name Oklahoma Medical Research Foundation, Oklahoma, USA
194 University of Oklahoma Health Sciences Center, Oklahoma City, USA
195 rdf:type schema:Organization
196 https://www.grid.ac/institutes/grid.274264.1 schema:alternateName Oklahoma Medical Research Foundation
197 schema:name Oklahoma Medical Research Foundation, Oklahoma, USA
198 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...